Another vaccine reduced the growth of 4T1 tumors by promoting production of cytotoxic T lymphocytes that killed CAFs, and the decrease in FAPα-expressing CAFs markedly decreased collagen I and other stromal factors, resulting in a marked attenuation of tumor progression (173). This evidence concerns the gene FAP and neoplasm.